Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of CS0159 tablets in primary biliary cholangitis
CTR20231402Phase 2Active
- Sponsor
- Cascade Pharmaceuticals
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linafexor in primary biliary cholangitis (PBC), sponsored by Cascade Pharmaceuticals. Started Aug 2023; status: active.
02
Drugs
linafexor
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on CTR20231402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231402.